There was a negative correlation between ESR1 and ROBO1 in all BRCA, but positive in BRCA-Basal patients, indicating that ROBO1 could be a good complementary gene as a biomarker for breast cancer since there are few markers for BRCA-Basal cancer patients. This evidence concerns the gene ROBO1 and breast carcinoma.